These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 31383376)

  • 1. Artificial Intelligence for Drug Toxicity and Safety.
    Basile AO; Yahi A; Tatonetti NP
    Trends Pharmacol Sci; 2019 Sep; 40(9):624-635. PubMed ID: 31383376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Use of Artificial Intelligence in Pharmacovigilance: A Systematic Review of the Literature.
    Salas M; Petracek J; Yalamanchili P; Aimer O; Kasthuril D; Dhingra S; Junaid T; Bostic T
    Pharmaceut Med; 2022 Oct; 36(5):295-306. PubMed ID: 35904529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intelligent Telehealth in Pharmacovigilance: A Future Perspective.
    Edrees H; Song W; Syrowatka A; Simona A; Amato MG; Bates DW
    Drug Saf; 2022 May; 45(5):449-458. PubMed ID: 35579810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial Intelligence for Unstructured Healthcare Data: Application to Coding of Patient Reporting of Adverse Drug Reactions.
    Létinier L; Jouganous J; Benkebil M; Bel-Létoile A; Goehrs C; Singier A; Rouby F; Lacroix C; Miremont G; Micallef J; Salvo F; Pariente A
    Clin Pharmacol Ther; 2021 Aug; 110(2):392-400. PubMed ID: 33866552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards early detection of adverse drug reactions: combining pre-clinical drug structures and post-market safety reports.
    Liu R; Zhang P
    BMC Med Inform Decis Mak; 2019 Dec; 19(1):279. PubMed ID: 31849321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial Intelligence Within Pharmacovigilance: A Means to Identify Cognitive Services and the Framework for Their Validation.
    Mockute R; Desai S; Perera S; Assuncao B; Danysz K; Tetarenko N; Gaddam D; Abatemarco D; Widdowson M; Beauchamp S; Cicirello S; Mingle E
    Pharmaceut Med; 2019 Apr; 33(2):109-120. PubMed ID: 31933254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacovigilance: Importance, concepts, and processes.
    Kumar A
    Am J Health Syst Pharm; 2017 Apr; 74(8):606-612. PubMed ID: 28235869
    [No Abstract]   [Full Text] [Related]  

  • 8. Trust but Verify: Lessons Learned for the Application of AI to Case-Based Clinical Decision-Making From Postmarketing Drug Safety Assessment at the US Food and Drug Administration.
    Ball R; Talal AH; Dang O; Muñoz M; Markatou M
    J Med Internet Res; 2024 Jun; 26():e50274. PubMed ID: 38842929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-4/13 Blockade and sleep-related adverse drug reactions in over 37,000 Dupilumab reports from the World Health Organization Individual Case Safety reporting pharmacovigilance database (VigiBase™): a big data and machine learning analysis.
    Alroobaea R; Rubaiee S; Hanbazazah AS; Jahrami H; Garbarino S; Damiani G; Wu J; Bragazzi NL
    Eur Rev Med Pharmacol Sci; 2022 Jun; 26(11):4074-4081. PubMed ID: 35731078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data.
    Martin GL; Jouganous J; Savidan R; Bellec A; Goehrs C; Benkebil M; Miremont G; Micallef J; Salvo F; Pariente A; Létinier L;
    Drug Saf; 2022 May; 45(5):535-548. PubMed ID: 35579816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial Intelligence and the Future of the Drug Safety Professional.
    Danysz K; Cicirello S; Mingle E; Assuncao B; Tetarenko N; Mockute R; Abatemarco D; Widdowson M; Desai S
    Drug Saf; 2019 Apr; 42(4):491-497. PubMed ID: 30343417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying the Severity of Adverse Drug Reactions Using Social Media: Network Analysis.
    Lavertu A; Hamamsy T; Altman RB
    J Med Internet Res; 2021 Oct; 23(10):e27714. PubMed ID: 34673524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating ADR mechanisms with Explainable AI: a feasibility study with knowledge graph mining.
    Bresso E; Monnin P; Bousquet C; Calvier FE; Ndiaye NC; Petitpain N; Smaïl-Tabbone M; Coulet A
    BMC Med Inform Decis Mak; 2021 May; 21(1):171. PubMed ID: 34039343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What place for intelligent automation and artificial intelligence to preserve and strengthen vigilance expertise in the face of increasing declarations?
    Pariente A; Micallef J; Lahouegue A; Molimard M; Auffret M; Chouchana L; Denis B; Faillie JL; Grandvuillemin A; Letinier L; Pierron E; Pons C; Pujade I; Rubino H; Salvo F
    Therapie; 2023; 78(1):131-143. PubMed ID: 36572627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring medicines use: the role of the clinical pharmacologist.
    Williams D
    Br J Clin Pharmacol; 2012 Oct; 74(4):685-90. PubMed ID: 22554404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Pilot, Predictive Surveillance Model in Pharmacovigilance Using Machine Learning Approaches.
    De Abreu Ferreira R; Zhong S; Moureaud C; Le MT; Rothstein A; Li X; Wang L; Patwardhan M
    Adv Ther; 2024 Jun; 41(6):2435-2445. PubMed ID: 38704799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural Language Processing and Its Implications for the Future of Medication Safety: A Narrative Review of Recent Advances and Challenges.
    Wong A; Plasek JM; Montecalvo SP; Zhou L
    Pharmacotherapy; 2018 Aug; 38(8):822-841. PubMed ID: 29884988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of medicines-Pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process.
    Kopciuch D; Zaprutko T; Paczkowska A; Ratajczak P; Zielińska-Tomczak Ł; Kus K; Nowakowska E
    Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1543-1551. PubMed ID: 31148344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leveraging Generative AI for Drug Safety and Pharmacovigilance.
    Mishra HP; Gupta R
    Curr Rev Clin Exp Pharmacol; 2024 Sep; ():. PubMed ID: 39238375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Veterinary pharmacovigilance in India: A need of hour.
    Kumar R; Kalaiselvan V; Verma R; Kaur I; Kumar P; Singh GN
    Indian J Pharmacol; 2017; 49(1):2-3. PubMed ID: 28458414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.